ALEXANDRIA, Va., April 7 -- United States Patent no. 12,593,988, issued on April 7, was assigned to QFR Solutions B.V. (Leiden, Netherlands).

"Method and device for determining a coronary microvascular resistance score" was invented by Javier Escaned-Barbosa (Madrid), Hernan David Mejia Renteria (Madrid) and Johan Hendrikus Christiaan Reiber (Rotterdam, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of determining a microvascular resistance score indicating perfusion of myocardial tissue in a body of a mammal is provided, comprising obtaining acquired blood pressure data and flow data of blood in a cardiac vessel while the mammal is in a first physiological state; obtaining throughflow d...